Cyclo Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Cyclo Therapeutics (CYTH) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Cyclo Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Cyclo Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cyclo Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $6.7k | 4.8k | 1.39 |
| 2023-09-30 | $125 | 88 | 1.42 |
| 2023-03-31 | $1.4k | 1.6k | 0.84 |
| 2022-12-31 | $4.0k | 2.8k | 1.42 |
| 2022-06-30 | $2.0k | 793 | 2.52 |
| 2022-03-31 | $7.0k | 2.3k | 3.06 |
| 2021-12-31 | $48k | 13k | 3.72 |
| 2021-09-30 | $269k | 40k | 6.74 |
| 2021-06-30 | $113k | 11k | 10.19 |
| 2021-03-31 | $6.0k | 698 | 8.60 |